Description
Composition- Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg
Mode of Action- Provides intensified glycemic control by increasing insulin secretion and improving peripheral insulin sensitivity.
USPs- Strong triple therapy; useful in uncontrolled diabetes; improves long-term glycemic control.
Prescribing Specialties- Diabetologist, Internal Medicine
